Showing 14,001 - 14,020 results of 15,193 for search '(( 50 ((mean decrease) OR (we decrease)) ) OR ( 59 ((nn decrease) OR (a decrease)) ))', query time: 0.39s Refine Results
  1. 14001

    Bendamustine treatment of haematological malignancies: significant risks of opportunistic viral, fungal and bacterial infections by Tony K.Y. Wu (12531048)

    Published 2022
    “…CMV reactivation occurred in 58 patients (19%) at a median age of 68 (39–85) years. Univariate analysis showed CMV reactivation to be significantly associated with elevated lactate dehydrogenase (<i>P</i> = 0.045), decreased albumin (<i>P</i> = 0.003) and older age (reactivation versus no reactivation: 66.3 ± 11.4 versus 59.4 ± 14.5 years, <i>P</i> = 0.0016). …”
  2. 14002

    Images analyzed for Table 1. by Erdyni N. Tsitsikov (20384719)

    Published 2024
    “…A 59 base pair long deletion occurred in the first intron of the <i>Rik</i> gene and disrupted its expression. …”
  3. 14003

    Structural analysis of wild type and mutated variants of CXCR4. by Bonoshree Sarkar (20469331)

    Published 2024
    “…<p>(a) G55 in the wild-type protein and Val55 in mutated protein forms 2 H-bonds with Thr51 and Val59; (b) His79 in wild type protein engages in 4 H-bonds with Lys75, Tyr76, Val82, and Ala83, while the mutated Pro79 forms only 1 H-bond with Ala83; (c) H-bond number again changed with Leu80 (with Tyr76, Ala83, and Asn84) mutation from 3 to 2 with Pro80 (with Ala83 and Ans84); meanwhile, (d) H-bond number decreased from 4 to 2 in the mutated version of H113 (Cys109, Cys109, Thr117, Asp171) to P113 (Tyr116, Thr117); (e) P299 and L299 both create 2 H-bond but with different amino acids, P299 with Tyr302, Cys295, and L299 with Tyr302, Ala303, respectively. …”
  4. 14004

    Video 3_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  5. 14005

    Video 6_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  6. 14006

    Video 1_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  7. 14007

    Video 5_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  8. 14008

    Data Sheet 1_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  9. 14009

    Image_1_Eosinophils at diagnosis are elevated in amyotrophic lateral sclerosis.JPEG by Jing Yang (13969)

    Published 2023
    “…Introduction<p>Amyotrophic lateral sclerosis (ALS) is a rare, devastating neurodegenerative disease that affects upper and lower motor neurons. …”
  10. 14010

    Data Sheet 2_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  11. 14011

    Data Sheet 3_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.pdf by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  12. 14012

    Video 7_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  13. 14013

    Video 2_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  14. 14014

    Video 4_Clinical feasibility study of transcatheter edge-to-edge mitral valve repair in dogs with the canine V-Clamp device.mp4 by Brianna M. Potter (20401199)

    Published 2024
    “…Device-related adverse event rate was 6.3% based on 3 events (single-leaflet device detachment, locking failure, locking failure with device embolization) in 59 implanted devices. All three events were nonfatal and successfully treated with a second device. …”
  15. 14015

    S1 Dataset - by Anotida R. Hove (20513536)

    Published 2025
    “…Lower education (AOR 5.24 [1.69: 16.19]), multigravida (AOR .47 [.31: .42]), not exercising pre-pregnancy (AOR 2.02 [1.30: 3.13]), perceived decreased current PA level (AOR 2.04 [1.22: 3.43]) and not being advised by a doctor on exercise (AOR 2.05 [1.04: 4.04]) were associated with physical inactivity. …”
  16. 14016

    Strontium ranelate inhibits wear particle-induced aseptic loosening in mice by Tianxiang Geng (6516632)

    Published 2019
    “…<div><p>The imbalance between bone formation and osteolysis plays a key role in the pathogenesis of aseptic loosening. …”
  17. 14017
  18. 14018

    EBBS frequencies, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…Lower education (AOR 5.24 [1.69: 16.19]), multigravida (AOR .47 [.31: .42]), not exercising pre-pregnancy (AOR 2.02 [1.30: 3.13]), perceived decreased current PA level (AOR 2.04 [1.22: 3.43]) and not being advised by a doctor on exercise (AOR 2.05 [1.04: 4.04]) were associated with physical inactivity. …”
  19. 14019

    EBBS summative indices, N = 517. by Anotida R. Hove (20513536)

    Published 2025
    “…Lower education (AOR 5.24 [1.69: 16.19]), multigravida (AOR .47 [.31: .42]), not exercising pre-pregnancy (AOR 2.02 [1.30: 3.13]), perceived decreased current PA level (AOR 2.04 [1.22: 3.43]) and not being advised by a doctor on exercise (AOR 2.05 [1.04: 4.04]) were associated with physical inactivity. …”
  20. 14020

    Table 1_Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044.docx by Xiao Li (107004)

    Published 2025
    “…The age-standardized incidence rate was 6.0 (5.5 to 6.5) per 100,000 people in 2019 and decreased to 5.9 (5.4 to 6.4) per 100,000 people in 2021. …”